✦ LIBER ✦

6078 Cetuximab plus FOLFIRI in 1st-line treatment of metastatic colorectal cancer: Quality of life (QoL) analysis of patients (pts) with KRAS wild-type (wt) tumours in the CRYSTAL trial

✍ Scribed by Lang, I.; Köhne, C.H.; Folprecht, G.; Nowacki, M.P.; Cascinu, S.; Shchepotin, I.; Maurel, J.; Cunningham, D.; Zubel, A.; Van Cutsem, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life analysis in patients wit

✍ Láng, István; Köhne, Claus-Henning; Folprecht, Gunnar; Rougier, Philippe; Curran 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 325 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB

6079 Overall survival of patients with K

✍ Bokemeyer, C.; Bondarenko, I.; Hartmann, J.T.; DeBraud, F.; Schuch, G.; Zubel, A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PCN70 Cost-Effectiveness of Cetuximab an

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

3617 POSTER Cost-Effectiveness of Cetuxi

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

6077 A meta-analysis of the CRYSTAL and

✍ Van Cutsem, E.; Rougier, P.; Köhne, C.; Stroh, C.; Schlichting, M.; Bokemeyer, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB